Literature DB >> 21482867

Seroreactivity against aqueous-soluble and detergent-soluble retinal proteins in posterior uveitis.

Audrey C Ko1, Jason P Brinton, Vinit B Mahajan, Bridget Zimmerman, Gregory S Brinton, Edwin M Stone, James C Folk, Robert F Mullins.   

Abstract

OBJECTIVE: To characterize the seroreactivity against retinal proteins in patients with posterior uveitis, retinal disease of noninflammatory origin, and healthy controls.
METHODS: Patients with posterior uveitis (n = 47), molecularly confirmed photoreceptor degenerations (n = 11), and healthy controls (n = 33) received dilated fundus examinations at the University of Iowa. Aqueous-soluble and detergent-soluble fractions of human retina were separated by gel electrophoresis and transferred to polyvinylidene fluoride membranes. Membranes were probed with patient serum samples to detect IgG, IgA, and IgM human antibodies that react with retinal antigens. The number of bands detected by Western blot was counted, and their molecular weights were determined.
RESULTS: Antibodies recognizing retinal proteins were found in healthy controls, in patients with posterior uveitis, and in patients with molecularly confirmed heritable retinal degenerations. In healthy controls, 42% of individuals had circulating autoantibodies that recognized retinal proteins. Healthy controls had a low odds ratio of serum reactivity to soluble antigens (0.7; 95% confidence interval [CI], 0.4-1.2). Patients with inflammatory retinal diseases and inherited retinal diseases had 4.89 (95% CI, 2.25-10.64; P < .001) and 2.71 (95% CI, 1.19-6.16; P = .02) times more activity against soluble retinal antigens compared with controls.
CONCLUSIONS: Healthy control patients exhibited a significantly higher level of background autoantibody activity against retinal proteins than previously reported. Antibody activity in healthy controls was primarily directed against membrane-bound retinal proteins, whereas in patients with pathologic retinal conditions, antibodies targeting nonmembrane-bound retinal proteins predominate.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21482867     DOI: 10.1001/archophthalmol.2011.65

Source DB:  PubMed          Journal:  Arch Ophthalmol        ISSN: 0003-9950


  8 in total

Review 1.  The enigma of autoimmune retinopathy.

Authors:  Farzin Forooghian; Sijia Cao; Jing Cui; Joanne A Matsubara
Journal:  Int Ophthalmol Clin       Date:  2015

Review 2.  Autoimmune retinopathy.

Authors:  Landon Grange; Monica Dalal; Robert B Nussenblatt; H Nida Sen
Journal:  Am J Ophthalmol       Date:  2013-09-29       Impact factor: 5.258

3.  Vitritis in pediatric genetic retinal disorders.

Authors:  Maria Stunkel; Sajag Bhattarai; Andrew Kemerley; Edwin M Stone; Kai Wang; Robert F Mullins; Arlene V Drack
Journal:  Ophthalmology       Date:  2014-09-10       Impact factor: 12.079

Review 4.  Autoimmune Retinopathy: Current Concepts and Practices (An American Ophthalmological Society Thesis).

Authors:  H Nida Sen; Landon Grange; Marib Akanda; Austin Fox
Journal:  Trans Am Ophthalmol Soc       Date:  2018-03-08

5.  AUTOIMMUNE RETINOPATHY MIMICKING HERITABLE RETINAL DEGENERATION IN A PATIENT WITH COMMON VARIABLE IMMUNE DEFICIENCY.

Authors:  Luke A Wiley; Elaine M Binkley; Adam P DeLuca; Grefachew Workalemahu; Nicole J Tatro; Meagan A Luse; Elizabeth L Kennedy; James C Folk; Todd E Scheetz; Zuhair K Ballas; Budd A Tucker; Robert F Mullins; Ian C Han; Edwin M Stone
Journal:  Retin Cases Brief Rep       Date:  2022-01-01

Review 6.  Impact of Autoantibodies against Glycolytic Enzymes on Pathogenicity of Autoimmune Retinopathy and Other Autoimmune Disorders.

Authors:  Grazyna Adamus
Journal:  Front Immunol       Date:  2017-04-28       Impact factor: 7.561

7.  B Cell Anomalies in Autoimmune Retinopathy (AIR).

Authors:  Elena Stansky; Angélique Biancotto; Pradeep K Dagur; Sapna Gangaputra; Benjamin Chaigne-Delalande; Robert B Nussenblatt; H Nida Sen; J Philip McCoy
Journal:  Invest Ophthalmol Vis Sci       Date:  2017-07-01       Impact factor: 4.799

Review 8.  An update on autoimmune retinopathy.

Authors:  Parthopratim Dutta Majumder; Alessandro Marchese; Francesco Pichi; Itika Garg; Aniruddha Agarwal
Journal:  Indian J Ophthalmol       Date:  2020-09       Impact factor: 1.848

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.